Gurgaon, India

Kapil Kumar

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.2

ph-index = 1


Location History:

  • Haryana, IN (2020)
  • Gurgaon, IN (2019 - 2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kapil Kumar: Innovator in Pharmaceutical Chemistry

Introduction

Kapil Kumar is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications. With a total of 4 patents to his name, his work is recognized for its innovative approaches to drug development.

Latest Patents

Kapil Kumar's latest patents include groundbreaking inventions such as "Pyrazole compounds and preparation thereof." This invention provides processes for the preparation of substituted pyrazole compounds that can be used as intermediates for the preparation of substituted piperidine urea compounds, which are useful for the treatment of dilated cardiomyopathy (DCM). Another significant patent is the "Process for preparation of halo substituted benzoic acid compound and intermediates thereof," which outlines a method for creating halo substituted benzoic acid compounds and their intermediates.

Career Highlights

Throughout his career, Kapil Kumar has worked with prominent companies in the pharmaceutical industry, including SRF Limited and Myokardia, Inc. His experience in these organizations has allowed him to hone his skills and contribute to various innovative projects.

Collaborations

Kapil has collaborated with talented professionals in his field, including Rajdeep Anand and Sunil Sharma. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Kapil Kumar stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…